923P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic head & neck squamous cell carcinoma – subgroup analysis of the PEVOsq basket trial

Autor: Le Tourneau, C., Ghiringhelli, F., Saada, E.B., Chaltiel, R., Vansteene, D., Durando, X., You, B., Borel, C., Bigot, F., Abdeddaim, C., Marret, G., Jeannot, E., Guerini Rocco, E., Frige, G., Servant, N., Dupain, C., Kamal, M., Legrand, F., Jimenez, M., Filleron, T.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S583-S583
Databáze: ScienceDirect